ACADIA Pharmaceuticals Dividends

ACAD Stock  USD 24.76  1.37  5.24%   
The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 284.98. ACADIA Pharmaceuticals' past performance could be the main factor of why investors trade ACADIA Pharmaceuticals stock today. Investors should clearly understand every aspect of the ACADIA Pharmaceuticals dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest ACADIA Pharmaceuticals' dividend schedule and payout information. ACADIA Pharmaceuticals dividends can also provide a clue to the current valuation of ACADIA Pharmaceuticals.
Last ReportedProjected for Next Year
Dividend Paid And Capex Coverage Ratio 271.41  284.98 
One of the primary advantages of investing in dividend-paying companies such as ACADIA Pharmaceuticals is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in ACADIA Pharmaceuticals must own a stock before its ex-dividend date to receive its next dividend.

Will Biotechnology sector continue expanding? Could ACADIA diversify its offerings? Factors like these will boost the valuation of ACADIA Pharmaceuticals. If investors know ACADIA will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ACADIA Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
1.128
Earnings Share
1.55
Revenue Per Share
6.251
Quarterly Revenue Growth
0.113
Return On Assets
0.0511
The market value of ACADIA Pharmaceuticals is measured differently than its book value, which is the value of ACADIA that is recorded on the company's balance sheet. Investors also form their own opinion of ACADIA Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ACADIA Pharmaceuticals' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because ACADIA Pharmaceuticals' market value can be influenced by many factors that don't directly affect ACADIA Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that ACADIA Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ACADIA Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, ACADIA Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Compare Dividends Across Peers

Specify up to 10 symbols: